IP Library Granted Patent US 12,558,414
Granted Patent B2
US 12,558,414 · App. 17/626,340 · Granted Feb 24, 2026

Method for vaccinating avians against reovirus

Inventors: Kristi Mae Dorsey (Shawnee, KS); Brianna Ford (Lenexa, KS); Christopher Luther (Lenexa, KS); John Knox Rosenberger (Lincoln University, PA)
Assignee: BIOMUNE COMPANY
A61K39/21A61K47/02A61K47/32A61K2039/545A61K2039/552A61K2039/55511
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,558,414
App. No.
17/626,340
Granted
Feb 24, 2026
Kind
B2
Abstract

The present invention relates to a method vaccinating avian against reovirus.

Claims (17)

1 . A method for vaccinating an avian against a reovirus or an associated disease, comprising administering to the avian a composition comprising at least one inactivated avian reovirus and an adjuvant comprising a lipophile and a polymer of acrylic or methacrylic acid, wherein the composition is administered to the avian between day 1 and day 14 of age.

2 . The method of claim 1 , wherein the composition is administered to the avian between day 1 and day 7 of age.

3 . The method of claim 2 , wherein the composition is administered to the avian within 24 hours post-hatching.

4 . The method of claim 1 , wherein the composition comprises at least two distinct inactivated avian reoviruses.

5 . The method of claim 1 , wherein the at least one inactivated avian reovirus is an avian pathogenic reovirus strain.

6 . The method of claim 1 , wherein the inactivated reovirus is selected from inactivated strains S1, S2, S3, S1133, 2408, SS412, 2177, 1703, 1733, 1123, ERS-1 and 3005.

7 . The method of claim 1 , wherein the composition comprises inactivated reovirus strains S1, S2 and S3.

8 . The method of claim 1 , wherein the composition is administered at a dose from 10 3 TCID 50 to 10 9 TCID 50 of antigenic material per avian.

9 . The method of claim 1 , wherein the lipophile is selected from the group consisting of medium chain EP triglycerides, medium chain triglycerides NF, medium chain fatty acid triglyceride JPE, caprylic/capric triglyceride, and combinations thereof.

10 . The method of claim 1 , wherein the adjuvant further comprises at least one compound selected from saline, sterol, alcohol, saponin, sodium hydroxide, and any combination thereof.

11 . The method of claim 1 , wherein the avian is a poultry.

12 . The method of claim 1 , wherein a further administration with a composition comprising at least one avian reovirus antigenic material administered to the avian between 6 to 18 weeks of age.

13 . The method of claim 12 , wherein the avian reovirus in the compositions is derived from a similar or a different avian reovirus strain.

14 . A method for inducing a protective immune response in an avian against at least one reovirus, comprising administering to said avian a vaccine comprising at least one antigenic material comprising at least one inactivated avian reovirus and an adjuvant comprising a lipophile and a polymer of acrylic or methacrylic acid, wherein the vaccine is administered to the avian between day 1 and day 14 of age.

15 . The method of claim 11 , wherein the poultry is a chicken.

16 . The method of claim 10 , wherein the sterol is cholesterol.

17 . The method of claim 10 , wherein the alcohol is selected from ethanol, isopropanol, butanol and combinations thereof.

Assignments (2)
NOTICE OF GRANT OF SECURITY INTEREST IN PATENTS Recorded Jan 2, 2024
From: CEVA ANIMAL HEALTH, LLC; BIOMUNE COMPANY; THUNDERSHIRT, LLC
To: NATIXIS, AS SECURITY AGENT
Reel/Frame 066163/0711 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 18, 2023
From: DORSEY, KRISTI MAE; FORD, BRIANNA; LUTHER, CHRISTOPHER; ROSENBERGER, JOHN KNOX
To: BIOMUNE COMPANY
Reel/Frame 064295/0779 →
Continuity (2)
Provisional Application 62873271 · Jul 12, 2019
Related Publication 20220288192A1 · Sep 15, 2022
References Cited (6)
US 11813321B2 · Dorsey · 2023 [cited by examiner]
WO WO2016086222 · 2016 [cited by applicant]
Written Opinion in International Application No. PCT/US2020/041793, Nov. 3, 2020, pp. 1-8. [cited by applicant]
Merino-Guzmán, R. et al., American Association of Avian Pathologists—2018 Annual meeting. [cited by applicant]
Niu, X. et al. “Preparation and evaluation of goose reovirus inactivated vaccine” [cited by applicant]
Anonymous, Lohmann Animal Health, “AviPro 431 ND-IB-BD3-REO” [cited by applicant]